The Faculdade de Ciências da Universidade de Lisboa has recognized Fernando Antunes, Chief Technology Officer (CTO) of Delox, with the prestigious Science & Innovation Merit Award 2023. This award celebrates Fernando’s contributions to advancing bio-decontamination technologies and highlights his leadership in creating solutions with real societal impact. The Science &...
DELOX INTRODUCES NEW LOGO REFLECTING BIO-DECONTAMINATION INNOVATION AND HYDROGEN PEROXIDE ROOTS
Delox is proud to announce the launch of our new logo, a symbol that captures our evolution as a company while staying true to our origins. This updated visual identity represents a fresh chapter in our journey, reflecting the simplicity and innovation that lie at the heart of our mission...
DELOX CSO JOÃO PIRES DA SILVA RECOGNIZED AMONG WORLD’S MOST CITED RESEARCHERS
Delox is proud to announce that our Chief Scientific Officer (CSO), João Pires da Silva, has been recognized as one of the most cited researchers worldwide. According to a study conducted by Stanford University, João is ranked in the top 2% of the most influential scientists in his field, a...
DELOX WINS EIC ACCELERATOR FUNDING AS THE ONLY STARTUP FOR PANDEMIC MANAGEMENT CHALLENGE
Delox is proud to announce its selection for funding by the European Innovation Council (EIC) Accelerator, joining 42 innovative companies chosen in the final 2023 cut-off. Notably, Delox was the sole startup selected under the EIC Accelerator Challenge: Aerosol and Surface Decontamination for Pandemic Management, underscoring our commitment to advancing...
FDA DESIGNATES VAPORIZED HYDROGEN PEROXIDE (VHP) AS A CATEGORY A STERILIZATION METHOD, STREAMLINING MEDICAL DEVICE APPROVAL
In January 2024, the U.S. Food and Drug Administration (FDA) officially recognized vaporized hydrogen peroxide (VHP) as an Established Category A sterilization method for medical devices. This reclassification acknowledges VHP's long-standing safety and effectiveness, simplifying the regulatory process for manufacturers utilizing this sterilization technique. Understanding the FDA's Reclassification Previously categorized...
DELOX SELECTED FOR NET ZERO HEALTH SYSTEMS PROGRAM: INITIATIVE BY STARTUP LISBOA AND ASTRAZENECA
Delox was honored to be selected for the Net Zero Health Systems Acceleration Program, an initiative by Startup Lisboa and AstraZeneca that sought to reduce healthcare’s environmental impact. The program brought together HealthTech startups dedicated to exploring innovative solutions for decarbonizing and fostering sustainable practices across the healthcare sector. During...
DELOX HOSTS PUBLIC PRESENTATION FOR DELOX ROBOT PROJECT
On June 27, 2023, Delox held a public event at Tec Labs, University of Lisbon, to showcase the latest advancements in our Delox Robot, including a live demonstration of the equipment. Attendees were invited to explore how Delox is advancing bio-decontamination technology and learn more about our innovative solution designed...
DELOX ROBOT SHOWCASED IN BIODECON DEMO WITH THE PORTUGUESE MILITARY
Delox, in June 2023, presented its Delox Robot prototype at a Portuguese Army (Exército Português) facility, offering a glimpse into our work on advanced bio-decontamination solutions designed for large enclosures. This marks a promising milestone as we expand our technology to meet the needs of sectors with high biosecurity demands....
DELOX’S SOLID HYDROGEN PEROXIDE FORMULATION RECEIVES NON-HAZARDOUS CLASSIFICATION
Delox is excited to announce a pivotal regulatory milestone in bio-decontamination technology. Our solid hydrogen peroxide formulation (DeloxHP) has received official classification as non-corrosive and non-hazardous from the Department of Transportation (DOT), meaning it is not categorized under Organic Peroxides. This distinction simplifies our product’s transportation, as no additional safety...
